Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 14, 2011
Molecular recognition at the active site of factor Xa: cation-π interactions, stacking on planar peptide surfaces, and replacement of structural waterLaura M Salonen, Mareike C Holland, Philip S J Kaib, et al.
The EMBO Journal|May 1, 1993
The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragmentsF K Winkler, D W Banner, C Oefner, et al.
Mabs|June 2, 2012
Generation, characterization and structural data of chymase binding proteins based on the human Fyn kinase SH3 domainDaniel Schlatter, Simon Brack, David W Banner, et al.
Chemistry & Biology|October 29, 2002
Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitorsSatoshi Sogabe, Miyako Masubuchi, Kiyoaki Sakata, et al.
European Journal of Medicinal Chemistry|February 10, 2009
Design of novel aminopyrrolidine factor Xa inhibitors from a screening hitKatrin Groebke Zbinden, Lilli Anselm, David W Banner, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2010
Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidateLilli Anselm, David W Banner, Jörg Benz, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitorsKatrin Groebke Zbinden, Ulrike Obst-Sander, Kurt Hilpert, et al.
Journal of Medicinal Chemistry|November 15, 2013
Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffoldsHans Hilpert, Harald Mauser, Roland Humm, et al.
Chemmedchem|September 8, 2011
Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environmentsLeo A Hardegger, Bernd Kuhn, Beat Spinnler, et al.
Pageof 16